Daily Archives: 27/11/2010

Cladribine Merck Oral Multiple Sclerosis therapy

Merck has developed oral therapy for relapsing forms of multiple sclerosis (MS). Cladribine is earlier known for treatment of cancer (leukemia) in intravenous administration. Now Merck licensing from Ivax (Teva subsidiary) has developed oral therapy for MS. This product is now at … Continue reading

Posted in Daily interesting IP news | Leave a comment